BlackRock Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q4
Sell
-14,350
Closed -$172K 2992
2015
Q3
$172K Sell
14,350
-10,315
-42% -$124K ﹤0.01% 2556
2015
Q2
$452K Buy
+24,665
New +$452K ﹤0.01% 2289